ARK Fintech Innovation ETF vs GeneDx Holdings Corp — how do they compare? ARK Fintech Innovation ETF trades at $42.86, while GeneDx Holdings Corp trades at $82 (market cap $2.44B). Which is the better fit depends on your goals.
| ARKF | WGS | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $58.82 | $167.51 |
52-Week Low | $36.14 | $34.51 |
Market Cap | — | $2.44B |
Enterprise Value | — | $2.48B |
Trailing returns across standard periods
ARKF is an actively managed ETF that invests in companies leading the way in fintech innovation. Key themes include mobile payments, digital wallets, blockchain technology, and frictionless funding platforms.
Read more on ARKF →GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →